secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABBOTT LABORATORIES (ABT)
CIK:        0000001800
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001104659-26-020509
Event type: debt
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abbott issues $20B multi-tranche notes; proceeds to fund Exact Sciences acquisition
--------------------------------------------------------------------------------

- Issued $20B in senior notes across 8 tranches: floating and fixed rates from 3.70% to 5.60%, maturities 2029-2066.
- Net proceeds will fund the Exact Sciences acquisition, repay Exact Sciences debt, and for general corporate purposes.
- Underwriters include Morgan Stanley, Barclays, BofA Securities, and J.P. Morgan Securities.
- Closing expected on March 9, 2026, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800/000110465926020509/0001104659-26-020509-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800/000110465926020509/tm264905d7_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-020509

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer